glycine and pirenzepine

glycine has been researched along with pirenzepine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K	1
Andrioli, GC; Cavazzani, P; Marchi, M; Raiteri, M; Russo, C	1
Bar, G; Ermilov, M; Heresco-Levy, U; Javitt, DC; Lichtenberg, P	1

Trials

1 trial(s) available for glycine and pirenzepine

Article	Year
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biological psychiatry, 2004, Jan-15, Volume: 55, Issue:2 Topics: Adult; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycine; Humans; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Serine; Time Factors; Treatment Outcome	2004

Article

Year

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

Biological psychiatry, 2004, Jan-15, Volume: 55, Issue:2

Topics: Adult; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycine; Humans; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Serine; Time Factors; Treatment Outcome

2004

Other Studies

2 other study(ies) available for glycine and pirenzepine

Article	Year
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21 Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship	2010
Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1 Topics: Acetylcholine; Alkaloids; Cerebral Cortex; Cholinergic Fibers; Drug Synergism; Female; Furans; Glycine; Humans; Kinetics; Male; Muscarinic Antagonists; Naphthalenes; Parasympatholytics; Piperidines; Pirenzepine; Potassium Chloride; Receptors, Muscarinic; Stimulation, Chemical; Synaptic Transmission; Synaptosomes; Tritium	1993

Article

Year

Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de

Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship

2010

Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.

The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1

Topics: Acetylcholine; Alkaloids; Cerebral Cortex; Cholinergic Fibers; Drug Synergism; Female; Furans; Glycine; Humans; Kinetics; Male; Muscarinic Antagonists; Naphthalenes; Parasympatholytics; Piperidines; Pirenzepine; Potassium Chloride; Receptors, Muscarinic; Stimulation, Chemical; Synaptic Transmission; Synaptosomes; Tritium

1993